Matthew K Fust Insider Trading
Get free email notifications about insider trading for Matthew K Fust.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew K Fust. Matthew K Fust is a EVP and CFO in Jazz Pharmaceuticals plc ($JAZZ) and a EVP, Chief Financial Officer in Jazz Pharmaceuticals plc ($JAZZ) and a Senior Vice President & CFO in Jazz Pharmaceuticals plc ($JAZZ) and a SVP and CFO in Jazz Pharmaceuticals plc ($JAZZ) and a Director in MACROGENICS INC ($MGNX) and a in Ultragenyx Pharmaceutical Inc. ($RARE) and a Director in Ultragenyx Pharmaceutical Inc. ($RARE) and a in Dermira, Inc. ($DERM) and a Director in Dermira, Inc. ($DERM) and a Director in Atara Biotherapeutics, Inc. ($ATRA) and a Director in Crinetics Pharmaceuticals, Inc. ($CRNX).
Address: C/O JAZZ PHARMACEUTICALS, INC. 3180 PORTER DRIVE PALO ALTO 94304 CA
Companies in which Matthew K Fust is an Insider
Atara Biotherapeutics, Inc.
Trading Symbol: ATRAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Matthew K Fust: Director
Holdings: 33,854 shares
Current Value: $509,503
Latest Transaction: Jun 17 2020
$ATRA Market Capitalization: $434.34M
$ATRA Previous Close: $15.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Crinetics Pharmaceuticals, Inc.
Trading Symbol: CRNXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew K Fust: Director
Holdings: 16,036 shares
Latest Transaction: Jun 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dermira, Inc.
Trading Symbol: DERMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew K Fust:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 24 2020
$DERM Market Capitalization: $1.02B
$DERM Previous Close: $29.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Jazz Pharmaceuticals plc
Trading Symbol: JAZZIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew K Fust: EVP, Chief Financial Officer, EVP and CFO, SVP and CFO, Senior Vice President & CFO
Holdings: 58,948 shares
Current Value: $7,371,447
Latest Transaction: Dec 01 2008
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MACROGENICS INC
Trading Symbol: MGNXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew K Fust: Director
Holdings: 7,424 shares
Current Value: $138,309
Latest Transaction: May 20 2019
$MGNX Market Capitalization: $637.48M
$MGNX Previous Close: $18.63
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ultragenyx Pharmaceutical Inc.
Trading Symbol: RAREIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew K Fust: Director
Holdings: 19,731 shares
Current Value: $1,438,587
Latest Transaction: Jul 08 2020
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Matthew K Fust
Sentiment: All, ATRA, CRNX, DERM, JAZZ, MGNX, RARE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 08 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Option Exercise | M | 21.00 | 6,181 | 129,801 | 0 | |
Jul 08 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Sell | S | 90.00 | 6,181 | 556,290 | 13,550 | 19.7 K to 13.6 K (-31.33 %) |
Jul 08 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Buy | M | 21.00 | 6,181 | 129,801 | 19,731 | 13.6 K to 19.7 K (+45.62 %) |
Jul 06 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Option Exercise | M | 21.00 | 5,000 | 105,000 | 6,181 | |
Jul 06 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Sell | S | 85.00 | 5,000 | 425,000 | 13,550 | 18.6 K to 13.6 K (-26.95 %) |
Jul 06 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Buy | M | 21.00 | 5,000 | 105,000 | 18,550 | 13.6 K to 18.6 K (+36.90 %) |
Jun 30 2020 | RARE | Ultragenyx Pharmac ... | Fust Matthew K | Director | Option Exercise | A | 76.58 | 4,250 | 325,465 | 4,250 |